Market Cap 11.50B
Revenue (ttm) 5.37B
Net Income (ttm) 455.70M
EPS (ttm) N/A
PE Ratio 22.20
Forward PE 21.66
Profit Margin 8.48%
Debt to Equity Ratio 0.78
Volume 599,300
Avg Vol 739,458
Day's Range N/A - N/A
Shares Out 100.62M
Stochastic %K 25%
Beta 0.91
Analysts Strong Sell
Price Target $140.25

Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plan...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 205 967 7116
Address:
9001 Liberty Parkway, Birmingham, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:57 AM
$EHC is currently trading at $113.46, showing a significant bearish sentiment with an RSI of 18.06, indicating it is oversold and may be due for a rebound. The price is below both the 30-day MA of $120.83 and the 50-day MA of $122.62, reinforcing the current downtrend. The recent 60-day high of $127.99 and low of $107.52 suggests a trading range, with the potential for a bounce near the low. Directional bias is bearish in the short term due to the RSI and MAs, but the extreme RSI indicates a possible reversal. A suggested entry point could be around $110, slightly above the 60-day low. Set a stop loss at $107 to manage risk. For targets, aim for $115, where the price could face resistance near the 30-day MA, and a more aggressive target at $120, aligning with the 30-day MA. Monitor the market closely for any changes in sentiment. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:19 AM
$EHC is currently trading at $113.46, well below its 30-day moving average (MA30) of $120.83 and 50-day moving average (MA50) of $122.62, indicating a bearish trend. The RSI at 18.06 suggests that the stock is significantly oversold, which may lead to a potential reversal or short-term bounce. The 60-day high of $127.99 and low of $107.52 establishes a range, with current price closer to the low, reinforcing downside risk. Suggested trade plan: Look for a potential entry around $112.00, anticipating a bounce due to the oversold RSI. Set a stop loss at $106.00 to manage risk. Target 1 can be set at $118.00, aligning with the MA30, and Target 2 at $122.00, near the MA50. This plan capitalizes on a possible short-term recovery while maintaining a clear risk management strategy. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:52 AM
$EHC is currently trading at $114.28, significantly below its 30-day moving average (MA30) of $121.15 and 50-day moving average (MA50) of $122.86, indicating a bearish trend. The RSI of 22.71 suggests that the stock is oversold, which may lead to a potential reversal, but caution is warranted due to the overall downward momentum. Given the 60-day high of $127.99 and low of $107.52, the stock is positioned near the lower end of this range, providing a possible short-term buying opportunity. Suggested trade plan: - Entry: $112.50 (anticipating a bounce from the low end of the range) - Stop: $107.00 (to limit losses if the downtrend continues) - Target 1: $120.00 (near MA30) - Target 2: $125.00 (mid-range target) Monitor RSI for signs of reversal and adjust targets accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:59 AM
$EHC is currently trading at $115.56, significantly below its 30-day moving average (MA30) of $121.79 and 50-day moving average (MA50) of $123.24, indicating a bearish trend. The RSI of 24.21 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. The recent 60-day high of $127.99 and low of $107.52 creates a range that suggests volatility, with the current price closer to the low. For a trade plan, consider entering a long position around $115.00, anticipating a bounce due to the oversold RSI. Set a stop loss at $112.00 to manage risk. Target 1 at $120.00 aligns with the MA30, and Target 2 at $125.00 reflects a rebound towards the 60-day high. Monitor for signs of reversal or further weakness in the market context. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:35 AM
$EHC is currently trading at $115.56, significantly below its 30-day moving average (MA30) of $121.79 and 50-day moving average (MA50) of $123.24, indicating a bearish trend. The RSI of 24.21 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. The recent 60-day high of $127.99 and low of $107.52 creates a range that suggests volatility, with the current price closer to the low. For a trade plan, consider entering a long position around $115.00, anticipating a bounce due to the oversold RSI. Set a stop loss at $112.00 to manage risk. Target 1 at $120.00 aligns with the MA30, and Target 2 at $125.00 reflects a rebound towards the 60-day high. Monitor for signs of reversal or further weakness in the market context. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 6:38 PM
$EHC drops 8% even after a Q3 beat ⚠️ Higher costs overshadowed solid revenue growth, new bed expansions, and an optimistic 2025 outlook — a mixed setup for the stock. Full breakdown of what’s weighing on Encompass Health 👉 https://www.zacks.com/stock/news/2789505/encompass-health-shares-down-8-despite-q3-earnings-revenue-beat?cid=sm-stocktwits-2-2789505-teaser-20570&ADID=SYND_STOCKTWITS_TWEET_2_2789505_TEASER_20570
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 5:38 PM
$EHC down 8.3% post-Q3 results — what's driving the slide? 📉 Despite a 19.4% year-over-year EPS boost, surpassing the Zacks Consensus Estimate by 3.4%, and a raised 2025 outlook that may favor investor sentiment, rising operating expenses from increased salaries and benefits are weighing on investor sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2789505/encompass-health-shares-down-8-despite-q3-earnings-revenue-beat?cid=sm-stocktwits-2-2789505-body-20555&ADID=SYND_STOCKTWITS_TWEET_2_2789505_BODY_20555
0 · Reply
CourageJD
CourageJD Nov. 5 at 12:43 AM
$EHC what the fuck after hours
0 · Reply
IN0V8
IN0V8 Oct. 30 at 1:38 PM
$EHC bought at $109.81
1 · Reply
CourageJD
CourageJD Oct. 29 at 3:10 PM
$EHC watching this tonight for earnings. Might be goonin to it if it goes the right way
0 · Reply
Latest News on EHC
Rehabilitation Hospital of Amarillo now open in Texas

Nov 10, 2025, 4:34 PM EST - 4 days ago

Rehabilitation Hospital of Amarillo now open in Texas


Encompass Health reports results for third quarter 2025

Oct 29, 2025, 4:20 PM EDT - 16 days ago

Encompass Health reports results for third quarter 2025


Encompass Health declares dividend on common stock

Oct 23, 2025, 9:48 AM EDT - 23 days ago

Encompass Health declares dividend on common stock


Encompass Health reports results for second quarter 2025

Aug 4, 2025, 4:20 PM EDT - 3 months ago

Encompass Health reports results for second quarter 2025


Encompass Health increases and declares dividend on common stock

Jul 24, 2025, 8:50 AM EDT - 4 months ago

Encompass Health increases and declares dividend on common stock


Rehabilitation Hospital of Fort Myers now open in Florida

May 20, 2025, 1:05 PM EDT - 6 months ago

Rehabilitation Hospital of Fort Myers now open in Florida


Encompass Health reports results for first quarter 2025

Apr 24, 2025, 4:20 PM EDT - 7 months ago

Encompass Health reports results for first quarter 2025


Encompass Health announces annual stockholder meeting date

Apr 16, 2025, 4:30 PM EDT - 7 months ago

Encompass Health announces annual stockholder meeting date


Rehabilitation Hospital of Athens Now Open in Georgia

Mar 18, 2025, 2:28 PM EDT - 8 months ago

Rehabilitation Hospital of Athens Now Open in Georgia


Encompass Health Declares Dividend on Common Stock

Feb 20, 2025, 8:58 AM EST - 9 months ago

Encompass Health Declares Dividend on Common Stock


PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:57 AM
$EHC is currently trading at $113.46, showing a significant bearish sentiment with an RSI of 18.06, indicating it is oversold and may be due for a rebound. The price is below both the 30-day MA of $120.83 and the 50-day MA of $122.62, reinforcing the current downtrend. The recent 60-day high of $127.99 and low of $107.52 suggests a trading range, with the potential for a bounce near the low. Directional bias is bearish in the short term due to the RSI and MAs, but the extreme RSI indicates a possible reversal. A suggested entry point could be around $110, slightly above the 60-day low. Set a stop loss at $107 to manage risk. For targets, aim for $115, where the price could face resistance near the 30-day MA, and a more aggressive target at $120, aligning with the 30-day MA. Monitor the market closely for any changes in sentiment. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:19 AM
$EHC is currently trading at $113.46, well below its 30-day moving average (MA30) of $120.83 and 50-day moving average (MA50) of $122.62, indicating a bearish trend. The RSI at 18.06 suggests that the stock is significantly oversold, which may lead to a potential reversal or short-term bounce. The 60-day high of $127.99 and low of $107.52 establishes a range, with current price closer to the low, reinforcing downside risk. Suggested trade plan: Look for a potential entry around $112.00, anticipating a bounce due to the oversold RSI. Set a stop loss at $106.00 to manage risk. Target 1 can be set at $118.00, aligning with the MA30, and Target 2 at $122.00, near the MA50. This plan capitalizes on a possible short-term recovery while maintaining a clear risk management strategy. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:52 AM
$EHC is currently trading at $114.28, significantly below its 30-day moving average (MA30) of $121.15 and 50-day moving average (MA50) of $122.86, indicating a bearish trend. The RSI of 22.71 suggests that the stock is oversold, which may lead to a potential reversal, but caution is warranted due to the overall downward momentum. Given the 60-day high of $127.99 and low of $107.52, the stock is positioned near the lower end of this range, providing a possible short-term buying opportunity. Suggested trade plan: - Entry: $112.50 (anticipating a bounce from the low end of the range) - Stop: $107.00 (to limit losses if the downtrend continues) - Target 1: $120.00 (near MA30) - Target 2: $125.00 (mid-range target) Monitor RSI for signs of reversal and adjust targets accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:59 AM
$EHC is currently trading at $115.56, significantly below its 30-day moving average (MA30) of $121.79 and 50-day moving average (MA50) of $123.24, indicating a bearish trend. The RSI of 24.21 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. The recent 60-day high of $127.99 and low of $107.52 creates a range that suggests volatility, with the current price closer to the low. For a trade plan, consider entering a long position around $115.00, anticipating a bounce due to the oversold RSI. Set a stop loss at $112.00 to manage risk. Target 1 at $120.00 aligns with the MA30, and Target 2 at $125.00 reflects a rebound towards the 60-day high. Monitor for signs of reversal or further weakness in the market context. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:35 AM
$EHC is currently trading at $115.56, significantly below its 30-day moving average (MA30) of $121.79 and 50-day moving average (MA50) of $123.24, indicating a bearish trend. The RSI of 24.21 suggests that the stock is oversold, which could lead to a potential reversal or short-term bounce. The recent 60-day high of $127.99 and low of $107.52 creates a range that suggests volatility, with the current price closer to the low. For a trade plan, consider entering a long position around $115.00, anticipating a bounce due to the oversold RSI. Set a stop loss at $112.00 to manage risk. Target 1 at $120.00 aligns with the MA30, and Target 2 at $125.00 reflects a rebound towards the 60-day high. Monitor for signs of reversal or further weakness in the market context. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 6:38 PM
$EHC drops 8% even after a Q3 beat ⚠️ Higher costs overshadowed solid revenue growth, new bed expansions, and an optimistic 2025 outlook — a mixed setup for the stock. Full breakdown of what’s weighing on Encompass Health 👉 https://www.zacks.com/stock/news/2789505/encompass-health-shares-down-8-despite-q3-earnings-revenue-beat?cid=sm-stocktwits-2-2789505-teaser-20570&ADID=SYND_STOCKTWITS_TWEET_2_2789505_TEASER_20570
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 5:38 PM
$EHC down 8.3% post-Q3 results — what's driving the slide? 📉 Despite a 19.4% year-over-year EPS boost, surpassing the Zacks Consensus Estimate by 3.4%, and a raised 2025 outlook that may favor investor sentiment, rising operating expenses from increased salaries and benefits are weighing on investor sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2789505/encompass-health-shares-down-8-despite-q3-earnings-revenue-beat?cid=sm-stocktwits-2-2789505-body-20555&ADID=SYND_STOCKTWITS_TWEET_2_2789505_BODY_20555
0 · Reply
CourageJD
CourageJD Nov. 5 at 12:43 AM
$EHC what the fuck after hours
0 · Reply
IN0V8
IN0V8 Oct. 30 at 1:38 PM
$EHC bought at $109.81
1 · Reply
CourageJD
CourageJD Oct. 29 at 3:10 PM
$EHC watching this tonight for earnings. Might be goonin to it if it goes the right way
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 22 at 3:37 PM
$EHC Share Price: $126.28 Contract Selected: Apr 17, 2026 $125 Calls Buy Zone: $8.16 – $10.08 Target Zone: $14.81 – $18.11 Potential Upside: 71% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 8:35 AM
Enter: $EHC NOV 21 2025 $125 CALLS Buy in Price: $4.40 - $5.00 Take Profit: $8.71 Stop Bleeding: $3.87 ROI Potential: 98% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 8:13 PM
Enter: $EHC NOV 21 2025 $135 CALLS Buy in Price: $2.24 - $3.80 Take Profit: $4.44 Stop Bleeding: $1.97 ROI Potential: 98% Exit Within: 359 Minutes https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Sep. 26 at 6:45 PM
$EHC expands footprint 🚀 First rehab hospital in Connecticut now open in Danbury — fueling nationwide growth and tapping into rising demand for specialized care. See the expansion story here 👉 https://www.zacks.com/stock/news/2757931/encompass-health-opens-first-connecticut-rehab-hospital-in-danbury?cid=sm-stocktwits-2-2757931-teaser-14400&ADID=SYND_STOCKTWITS_TWEET_2_2757931_TEASER_14400
0 · Reply
ZacksResearch
ZacksResearch Sep. 26 at 5:45 PM
$EHC expands with its first CT hospital! 🚀 With the opening in Danbury, EHC strengthens its national network, marking the 170th hospital as demand for rehab care rises. Expecting 2025 revenues of $5.88-$5.98B, EHC is on a growth trajectory. Discover how EHC is expanding its footprint in rehab care 👉 https://www.zacks.com/stock/news/2757931/encompass-health-opens-first-connecticut-rehab-hospital-in-danbury?cid=sm-stocktwits-2-2757931-body-14394&ADID=SYND_STOCKTWITS_TWEET_2_2757931_BODY_14394
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 25 at 9:31 PM
Enter: $EHC OCT 17 2025 $130 CALLS Buy in Price: $1.27 - $2.40 Take Profit: $1.63 Stop Bleeding: $1.12 ROI Potential: 28% Exit Within: 310 Minutes https://moneygroup.us/alerts
0 · Reply
JamesDettman235
JamesDettman235 Sep. 21 at 10:39 AM
$EHC Healthcare giant stability. Defensive characteristics. Dividend support strong. Relative strength.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 21 at 7:51 AM
Enter: $EHC OCT 17 2025 $125 CALLS Buy in Price: $2.91 - $3.10 Take Profit: $5.59 Stop Bleeding: $2.56 ROI Potential: 92% Exit Within: 350 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 19 at 7:14 AM
Enter: $EHC OCT 17 2025 $125 CALLS Buy in Price: $2.91 - $3.40 Take Profit: $5.30 Stop Bleeding: $2.56 ROI Potential: 82% Exit Within: 153 Minutes https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Sep. 16 at 1:00 PM
Keybanc has updated their rating for Encompass Health ( $EHC ) to Overweight with a price target of 140.
0 · Reply
ShortMaxx
ShortMaxx Sep. 15 at 8:57 AM
$EHC Favorable secular trends but execution risk remains
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 6:00 PM
$EHC is doubling down on growth 🚀 The new 50-bed rehab hospital in The Villages expands their Central Florida footprint and strengthens their patient care network. Full expansion details here 👉 https://www.zacks.com/stock/news/2749682/encompass-health-opens-new-rehabilitation-hospital-in-the-villages?cid=sm-stocktwits-2-2749682-teaser-11874&ADID=SYND_STOCKTWITS_TWEET_2_2749682_TEASER_11874
0 · Reply